PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-naïve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b

NCT01066819 · clinicaltrials.gov ↗

COMPLETED

Status

1656

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Peginterferon alfa-2a [Pegasys]
DRUG: Peginterferon alfa-2b [PegIntron®]

Sponsor

Hoffmann-La Roche